The addition of PD-1 inhibitors to first-line treatment with transarterial chemoembolization (TACE) plus lenvatinib for ...

Researchers from the University of Manchester sought to understand whether the season of administration of immunotherapy ...

Research highlighted the pivotal role of P2RX7 in driving inflammatory and fibrotic processes in idiopathic pulmonary ...

Underserved communities, already facing higher asthma prevalence due to social determinants of health, are disproportionately ...

FoundationOne Liquid CDx can be used to identify niraparib and abiraterone acetate eligibility in patients with metastatic ...

Digital twin technology could personalize treatment for pulmonary hypertension, according to a recent study.

e-Cigarette users may be less likely to undergo lung cancer screening, study reveals. "Emerging research suggests that ...

Investigators compared cost-effectiveness of the KRAS inhibitor sotorasib against the taxane docetaxel in the second line for ...

Sindhuja Kadambi, MD, MS, University of Rochester Medical Center, discussed in detail the unique considerations necessary for ...

Michael Thorpy, MD, professor of neurology, Albert Einstein College of Medicine, discusses the hopeful future of treatment in ...

In a recently published systematic review, researchers determined that VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory ...

Looking towards the future, what advancements do you anticipate in the treatment landscape for PNH and other ...